Shandong Weigao repurchases 500,000 shares, boosting treasury stock

Shandong Weigao Group Medical Polymer Company Limited disclosed its Next Day Disclosure Return on November 12, 2025, detailing a repurchase of its H shares. The company bought back 500,000 ordinary shares on the Exchange at prices ranging from HK$5.52 to HK$5.6, with an aggregate cost of HK$2,778,400.

This repurchase resulted in a change to both the issued and treasury share counts. The number of issued shares (excluding treasury shares) decreased by 500,000 to 4,497,922,324, a 0.0111% reduction from the previous balance. Concurrently, the number of treasury shares increased by 500,000, bringing the total to 24,410,000. The total number of issued shares remains unchanged at 4,522,332,324.

The company's latest repurchase falls under a mandate granted on May 27, 2025, which authorized the repurchase of up to 451,560,392 shares. With the latest transaction, Shandong Weigao has repurchased a total of 17,761,600 shares, representing 3.9334% of its issued shares (excluding treasury shares) as of the mandate date. A moratorium period for new share issues or sales of treasury shares will be in effect until December 11, 2025.